Guest Name and Bio:
Suneer “Sunny” Jain, M.S., Chief Executive Officer, Sun Genomics.
Mr. Jain earned his Bachelor of Science (B.S.) degree from the University of Iowa in 1999. He went on to graduate with a Masters in Anatomy and Cell Biology from the Department of Anatomy and Cell Biology at the University of Iowa in 2004, where he conducted research in the field of Microbiology and Gene Therapy. Following graduation, Mr. Jain began his career as a Research and Development Supervisor for Pathway Diagnostics. Here he developed new molecular biomarker assays for clinical trials and out-licensing opportunities, planned and performed studies for the development and optimization of molecular assay(s) such as RNA/DNA extractions, (q)RT-PCR, PCR, SNP genotyping, Indel detection, gene rearrangement, and mutation status. Mr. Jain focused his career in 2007 towards clinical patient testing while working for LabCorp in the molecular oncology laboratory. During his time at LabCorp, Sunny participated in the development and launch of new lymphoma and leukemia molecular assays such as T-Cell GR, BCR/ABL, improved and troubleshooted existing assays such as Jak2, FLT3, IgVh somatic hypermutation, B-Cell GR, and MSI; he also reviewed and oversaw the scheduling and completion of Proﬁciency testing for CAP and NYS, and submitted validations and received approval from the New York State DOH on multiple assays.
In 2009, Mr. Jain began working as a Lab Manager and Technical Supervisor in a Clinical Services Laboratory for industry leader, Illumina. At Illumina, Sunny managed the world’s first CLIA Whole Genome Sequencing Lab at Illumina for seven (7) years and was a part of the team that established the Illumina Clinical Services Laboratory and the first Clinical Laboratory to sequence the whole human genome in a CLIA-certified, CAP-accredited laboratory introducing NGS technology into a clinical setting. Additionally, he led a zero deficiency CAP inspection as acting quality manager/general supervisor/technical supervisor from 2011-2015, authored state of the art assay validation studies for Whole Genome Sequencing as an LDT, managed site relocation, re-verification studies, and HiSeq 2000 validations for Whole Genome Sequencing, and restructured payment processing workflow in a SAP for a laboratory generating over $5 Million per year.
What you will learn from this episode: 1) What is a precision probiotic? 2) Can probiotics help and how? 3) What is the best way to sequence the gut microbiome 4) How to take a highly personalized approach to gut health 5) Understanding how to optimize gut health
How to learn more about our guest: https://sungenomics.com/ https://www.instagram.com/sungenomics/ https://www.facebook.com/sungenomics/ https://www.linkedin.com/company/sungenomics/ https://twitter.com/sungenomics?lang=en
Please enjoy, share, rate and review our podcast and help us bring the message about precision health care to the world!